Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence and Antimicrobial Susceptibility Pattern of Extended Spectrum Beta Lactamase (ESBL) and non-ESBL Producing Enteric Gram-Negative Bacteria and Activity of Nitrofurantoin in the era of ESBL

Zohreh Aminzadeh 1 , 2 , * , Davood Yadegarynia 1 , Alireza Fatemi 1 , Saieed Azad Armaki 1 and Bahram Aslanbeygi 1
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Center for Clinical Research, University of Queensland, Brisbane, Australia
Article information
  • Jundishapur Journal of Microbiology: September 01, 2013, 6 (7); e6699
  • Published Online: September 1, 2013
  • Article Type: Research Article
  • Received: June 8, 2012
  • Revised: July 24, 2012
  • Accepted: August 8, 2012
  • DOI: 10.5812/jjm.6699

To Cite: Aminzadeh Z, Yadegarynia D, Fatemi A, Azad Armaki S, Aslanbeygi B. Prevalence and Antimicrobial Susceptibility Pattern of Extended Spectrum Beta Lactamase (ESBL) and non-ESBL Producing Enteric Gram-Negative Bacteria and Activity of Nitrofurantoin in the era of ESBL, Jundishapur J Microbiol. 2013 ; 6(7):e6699. doi: 10.5812/jjm.6699.

Abstract
Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Alipourfard I, Nili NY. Antibiogram of Extended Spectrum Beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae isolated from Hospital Samples. Bangladesh J Med Microbiol. 2010; 4(1): 32-36
  • 2. Du B, Long Y, Liu H, Chen D, Liu D, Xu Y, et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med. 2002; 28(12): 1718-23[DOI][PubMed]
  • 3. Paterson DL, Yu VL. Extended-spectrum beta-lactamases: a call for improved detection and control. Clin Infect Dis. 1999; 29(6): 1419-22[DOI][PubMed]
  • 4. Ramphal R, Ambrose PG. Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis. 2006; 42 Suppl 4-72[DOI][PubMed]
  • 5. Aminizadeh Z, Kashi MS. Prevalence of multi-drug resistance and pandrug resistance among multiple gram-negative species: experience in one teaching hospital, Tehran, Iran. Int Res J Microbiol. 2011; 2: 90-95
  • 6. Srinivasan A, Wolfenden LL, Song X, Mackie K, Hartsell TL, Jones HD, et al. An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med. 2003; 348(3): 221-7[DOI][PubMed]
  • 7. Kiska DL, Gilligan PH. Manual of clinical microbiology. 2003; 8(1): 719-28
  • 8. Troillet N, Samore MH, Carmeli Y. Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis. 1997; 25(5): 1094-8[PubMed]
  • 9. Krcmery V, Jr, Trupl J, Kunova A, Spanik S, Ilavska I, Hel'pianska L, et al. Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. Bratisl Lek Listy. 1996; 97(11): 647-51[PubMed]
  • 10. Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis. 2002; 34(3): 340-5[DOI][PubMed]
  • 11. Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol. 2003; 24(4): 284-95[DOI][PubMed]
  • 12. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45(4): 493-6[PubMed]
  • 13. Clinical and Laboratory Standard Methods. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement. 2007;
  • 14. Geng SN, Zhou XH, Rui YY, Wang Q, Zhang J. [Distribution and drug resistance spectrum analysis of 2478 clinical bacterial and Candida isolates]. Nan Fang Yi Ke Da Xue Xue Bao. 2007; 27(4): 524-7[PubMed]
  • 15. Akyar I. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital]. Mikrobiyol Bul. 2008; 42(4): 713-5[PubMed]
  • 16. Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J Infect Dev Ctries. 2008; 2(5): 354-8[PubMed]
  • 17. Grandesso S, Sapino B, Mazzucato S, Alessandrini R, Solinas M, Gion M. [Study on in-vitro susceptibility of ESBL-positive Escherichia coli isolated from urine specimens]. Infez Med. 2010; 18(3): 162-8[PubMed]
  • 18. Rafay AM, Al-Muharrmi Z, Toki R. Prevalence of extended-spectrum beta-lactamases-producing isolates over a 1-year period at a University Hospital in Oman. Saudi Med J. 2007; 28(1): 22-7[PubMed]
  • 19. Idowu OJ, Onipede AO, Orimolade AE, Akinyoola LA, Babalola GO. Extended-spectrum Beta-lactamase Orthopedic Wound Infections in Nigeria. J Glob Infect Dis. 2011; 3(3): 211-5[DOI][PubMed]
  • 20. Asha Pai KB, Rai Rekha, Sanjeev H, Karnaker Vimal Kumar, Prasad Krishna. Nitrofurantoin: An Alternative Therapy for Uncomplicated Cystitis in the Era of Antimicrobial Resistance. J Clin Diagn Res. 2011; 5: 964-6
  • 21. TEKİN Alicem, DAL Tuba, DEVECİ Özcan, TEKİN Recep, BOZDAĞ Hasan, ÖZEKİNCİ Tuncer. In Vitro Efficacy of Nitrofurantoin and Some Antibiotics in Escherichia coli Strains Isolated from Urine Cultures. New J Med. 2012; 29(2): 88-91
  • 22. Karlowsky JA, Thornsberry C, Jones ME, Sahm DF. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis. 2003; 36(2): 183-7[DOI][PubMed]
  • 23. Hamze M, Dabboussi F, Izard D. [Enterobacterial susceptibility to antibiotics in northern Lebanon (1998-2001)]. Sante. 2003; 13(2): 107-12[PubMed]
  • 24. Babypadmini S, Appalaraju B. Extended spectrum -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol. 2004; 22(3): 172-4[PubMed]
  • 25. Garau J. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. Clin Microbiol Infect. 2008; 14 Suppl 1: 198-202[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments